Immune Checkpoint Patient Stratification: A Central Laboratory Perspective
DIA China 2018 lecture
This presentation provides an overview of trends in immuno-oncology studies targeting PD-1 and PD-L1, and discusses recruitment for immune checkpoint inhibitor trials, and provides challenges and insights. This was presented by Q2 Solutions at the DIA China 2018 conference.
Download this presentation to learn more.
Patrice Hugo, PhD, Chief Scientific Officer